Search results
EMA Approves Biocon Biologics to Produce Biosimilar Bevacizumab - India Telecom News
India Telecom News· 6 days agoIn Short:Biocon Biologics, a subsidiary of Biocon Ltd, has gotten approval from the European Medicines Agency to produce biosimilar Bevacizumab, a cancer ...
Buy or sell: Vaishali Parekh recommends three stocks to buy today — June 27
Livemint· 4 days agoBuy or sell stocks: Vaishali Parekh has recommended three stocks to buy today — GMR Infra, Snowman...
Biocon Biologics Receives EMA Approval to Manufacture Bevacizumab in India
SiliconIndia· 2 days agoTeam siliconindiaBiocon Biologics, a subsidiary of Biocon, received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab in India. This ...
Biocon firm receives approval from EMA to make Bevacizumab for Europe
The Hindu· 7 days agoBiocon Biologics Ltd. approved by EMA to manufacture biosimilar Bevacizumab in Bengaluru, expanding capacity for cancer treatment.
Dividend Stocks: M&M, Piramal Ent, Tata Power, among others to trade ex-dividend next week; Check...
Livemint· 2 days agoDividend Stocks: Several companies including Mahindra & Mahindra, Piramal Enterprises, Tata Power,...
MC Inside Edge: Operators gear up for second innings in GNFC, Biocon finds new believers, broker...
CNBC Awaaz· 3 days agoA group of Gujarat-based operators is having another go at the GNFC stock. The stock jumped 2.8x...
HFT Scan: Ceat and India Cements in focus
CNBC Awaaz· 3 hours agoCeat and India Cements closed higher on June 28.
Stock market update: Nifty Pharma index advances 0.07%
The Economic Times· 5 days agoThe Nifty Pharma index closed 0.07 per cent up at 19545.35.
Kiran Mazumdar-Shaw spotted at the wedding of Vijay Mallya’s son, Sidhartha Mallya, in UK
Hindustan Times· 6 days agoKiran Mazumdar-Shaw was seen in photographs from Day 2 shared on Instagram by designer Manoviraj...
Sumadhura Group eyes over 3-fold turnover growth to Rs 5,000 cr in FY25
Business Standard India· 7 days agoSouth India-based real estate developer Sumadhura Group on Friday said it is eyeing over three-fold...